Search

Author/Creator Rizk, Matthew L.

1. Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin. Issue 5 (23rd January 2020)

Authors:
Bhagunde, Pratik; Colon‐Gonzalez, Francheska; Liu, Yang; Wu, Jin; Xu, Shiyao Sherrie; Garrett, Graigory; Jumes, Patricia; Lasseter, Kenneth; Marbury, Thomas; Rizk, Matthew L.; Lala, Mallika; Rhee, Elizabeth G.; Butterton, Joan R.; Boundy, Keith
Journal:
British journal of clinical pharmacology
Issue:
Volume 86:Issue 5(2020)
Page Start:
944
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Novel Gastroretentive Controlled Release Formulations for Once-Daily Administration: Assessment of Clinical Feasibility and Formulation Concept for Raltegravir. (November 2016)

Authors:
Krishna, Rajesh; Rizk, Matthew L.; Larson, Patrick J.; Schulz, Valerie; Friedman, Evan; Gupta, Pranav; Kesisoglou, Fillippos; Connor, Alyson; McDermott, John; Smith, Ronald; Evans, Philip
Journal:
Therapeutic innovation & regulatory science
Issue:
Volume 50:Number 6(2016:Nov.)
Page Start:
777
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Perspective on the State of Pharmacometrics and Systems Pharmacology Integration. (21st August 2018)

Authors:
Trame, Mirjam N.; Riggs, Matthew; Biliouris, Konstantinos; Marathe, Dhananjay; Mettetal, Jerome; Post, Teun M.; Rizk, Matthew L.; Visser, Sandra A. G.; Musante, Cynthia J.
Journal:
CPT: pharmacometrics & systems pharmacology
Issue:
Volume 7:Number 10(2018)
Page Start:
617
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Pharmacokinetic Interactions Between the Fixed‐Dose Combinations of Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine and Elbasvir/Grazoprevir in Healthy Adult Participants. Issue 7 (7th June 2019)

Authors:
Feng, Hwa‐Ping; Guo, Zifang; Fandozzi, Christine; Panebianco, Deborah; Caro, Luzelena; Wolford, Dennis; Dreyer, Daniel P.; Valesky, Robert; Martinho, Monika; Rizk, Matthew L.; Iwamoto, Marian; Yeh, Wendy W.
Journal:
Clinical pharmacology in drug development
Issue:
Volume 8:Issue 7(2019)
Page Start:
952
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID‐19 Infection. Issue 6 (1st September 2020)

Authors:
Nicol, Melanie R.; Joshi, Abhay; Rizk, Matthew L.; Sabato, Philip E.; Savic, Radojka M.; Wesche, David; Zheng, Jenny H.; Cook, Jack
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 108:Issue 6(2020)
Page Start:
1135
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Pharmacokinetics and Safety of Single Intravenous Doses of Ceftolozane/Tazobactam in Children With Proven or Suspected Gram-Negative Infection. Issue 11 (November 2018)

Authors:
Bradley, John S.; Ang, Jocelyn Y.; Arrieta, Antonio C.; Larson, Kajal B.; Rizk, Matthew L.; Caro, Luzelena; Yang, Shan; Yu, Brian; Johnson, Matthew G.; Rhee, Elizabeth G.
Journal:
Pediatric infectious disease journal
Issue:
Volume 37:Issue 11(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Pooled population pharmacokinetic model of imipenem in plasma and the lung epithelial lining fluid. (1st April 2016)

Authors:
van Hasselt, J. G. Coen; Rizk, Matthew L.; Lala, Mallika; Chavez‐Eng, Cynthia; Visser, Sandra A. G.; Kerbusch, Thomas; Danhof, Meindert; Rao, Gauri; van der Graaf, Piet H.
Journal:
British journal of clinical pharmacology
Issue:
Volume 81:Number 6(2016:Jun.)
Page Start:
1113
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Population Pharmacokinetic Analysis for Imipenem–Relebactam in Healthy Volunteers and Patients With Bacterial Infections. (4th October 2019)

Authors:
Bhagunde, Pratik; Patel, Parul; Lala, Mallika; Watson, Kenny; Copalu, William; Xu, Ming; Kulkarni, Pooja; Young, Katherine; Rizk, Matthew L.
Journal:
CPT: pharmacometrics & systems pharmacology
Issue:
Volume 8:Number 10(2019)
Page Start:
748
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Population pharmacokinetic analysis of raltegravir pediatric formulations in HIV‐infected children 4 weeks to 18 years of age. (13th April 2015)

Authors:
Rizk, Matthew L.; Du, Lihong; Bennetto‐Hood, Chantelle; Wenning, Larissa; Teppler, Hedy; Homony, Brenda; Graham, Bobbie; Fry, Carrie; Nachman, Sharon; Wiznia, Andrew; Worrell, Carol; Smith, Betsy; Acosta, Edward P.
Journal:
Journal of clinical pharmacology
Issue:
Volume 55:Number 7(2015:Jul.)
Page Start:
748
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗